SciBase Strengthens the US Organization With Experienced Leader in Dermatology
SciBase Strengthens the US Organization With Experienced Leader in Dermatology
STOCKHOLM, June 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of AI-based solutions for skin diseases, today announces that Leda Beaty has been appointed Head of US Commercial Operations.
斯德哥尔摩，2024 年 6 月 13 日 /PRNewswire/-- SciBase Holding AB（“SciBase”） （停止：SCIB），基于人工智能的皮肤病解决方案的领先开发商SciBase今天宣布，Leda Beaty已被任命为美国商业运营主管。
SciBase is pleased to announce that Leda will be heading the US commercial operations. With an extensive background in sales and commercialization across pharmaceutical, medical devices and biotechnology she brings over 27 years of experience to this pivotal role. Leda joins from DermTech Inc., a skin cancer detection company, where she was Senior National Director, responsible for creating partnerships with leading clinicians, building strategic partnerships and market expansion in dermatology.
SciBase很高兴地宣布，Leda将领导美国的商业业务。凭借在制药、医疗器械和生物技术领域的销售和商业化方面的广泛背景，她为这一关键职位带来了超过27年的经验。Leda从皮肤癌检测公司DermTech Inc. 加入，她曾担任该公司的全国高级董事，负责与领先的临床医生建立合作关系，建立战略合作关系并扩大皮肤病学的市场。
Her expertise spans startup environments and the successful launches of products at renowned companies including Aventis, Amgen, Arthrex and DermTech. Leda has concentrated her efforts in the field of dermatology. Her experience in launching and driving sales of new products and technologies, building winning teams in the US dermatology market as well as experience in cost reimbursement in the US, will be key to driving SciBase US sales and market establishment forward.
她的专业知识涵盖创业环境以及安万特、安进、Arthrex和DermTech等知名公司的产品成功推出。Leda将精力集中在皮肤病学领域。她在推出和推动新产品和技术的销售、在美国皮肤科市场建立成功团队方面的经验以及在美国成本报销方面的经验，将是推动SciBase美国销售和市场建立向前发展的关键。
"We see Leda's experience as instrumental for driving growth and making SciBase successful in the U.S. as we build on the base we have now created for further expansion", says Pia Renaudin, CEO of SciBase.
SciBase首席执行官皮亚·雷诺丁表示：“我们认为Leda的经验对于推动增长和使SciBase在美国取得成功至关重要，因为我们在现在为进一步扩张而建立的基础上再接再厉。”
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
欲了解更多信息，请联系：
Pia Renaudin，VD，电话 +46732069802，电子邮件：[email protected]
Certified Advisor (CA):
认证顾问 (CA)：
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
Vator 证券
电话：+46 8 580 065 99
电子邮件：[电子邮件保护]
About SciBase:
关于 SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase 是一家全球医疗技术公司，专门从事皮肤病学的早期发现和预防。SciBase 开发并商业化了 Nevisense，这是一个独特的即时护理平台，它结合了人工智能（人工智能）和先进的 EIS 技术，可提高诊断准确性，确保积极的皮肤健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我们的承诺是最大限度地减少患者的痛苦，使临床医生能够通过及时的检测和干预来改善和挽救生命，并降低医疗成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase建立在瑞典斯德哥尔摩卡罗林斯卡研究所20多年的研究基础上，是皮肤病学进步领域的领导者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
该公司自2015年6月2日起在纳斯达克第一北方成长市场交易所上市。要了解更多，请访问。所有新闻稿和财务报告都可以在这里找到：
This information was brought to you by Cision
这些信息是由 Cision 带给你的
The following files are available for download:
以下文件可供下载：
|
PM_Leda US eng_final |
|
pm_leda 美国 eng_final |
SOURCE SciBase
来源 SciBase